Welcome to “The Use-Case” a mini-series brought to you by Scenius Studio
Through Scenius Studio, Ben has interviewed 50 of the crypto industry’s top GPs and CIOs across liquid and private markets. One thing is clear, crypto has some savvy investors. Yet, both inside and outside the industry, the same question lingers: where are the real-world use-cases? We’ve built the infrastructure, but where are the apps? What commercial opportunities can blockchain and crypto uniquely unlock? Is speculation really the only game in town?
With The Use-Case, we’re spotlighting underrepresented companies and protocols that are building real, commercially viable businesses—ventures that couldn’t exist without crypto’s underlying technology. We’ll sit down with Founders and CEOs who are reshaping industries with blockchain at their core. Crypto isn’t just an asset class. it’s an enabling technology rewiring entire sectors.
If you find this mini-series valuable, subscribe and share Scenius Studio with your network. See below for details on this week’s episode.
In this episode, Ben sits down with Tuan Cao, Co-Founder of LifeAI.
Tuan and his team started by building a Web2 alternative to 23andMe focused on the Asian genome, but with a key difference…they gave users full control over their data. That was just the beginning of a long-road to build one of the industry’s leading decentralized science projects. Long before “DeSci” was even a term, LifeAI has been building a decentralized foundation for genetics-based medicine and research. Today, Life has established itself as a base layer protocol that traditional healthcare players are building on top of cheaply and quickly. The future of genetics based personalized treatments might have crypto under the hood.
See below👇 for a sneak peak of the episode, links to the podcast, and an overview of the topics discussed.
Spotify
Apple
In this episode we discuss:
Why Tuan and team built a 23&Me competitor
Building a web2 genetics business and converting it into a blockchain-based protocol
Defining Decentralized Science (DeSci) and the different sections within the category
What applications are being built on top of the Life protocol
How the Life team enables privacy and data ownership using GeneNFTs
Cost savings and operational efficiencies gained from building your medical home base on-chain
We hope you enjoy listening to this conversation with Tuan. If you got any value out of the podcast then please consider sharing Scenius Studio with your network 💪